Literature DB >> 3298851

A molecular-pathologic approach to murine senile amyloidosis. Serum precursor-apolipoprotein A-II variant (Pro5----Gln) presents only in the senile amyloidosis-prone SAM-P/1 and SAM-P/2 mice.

T Yonezu, S Tsunasawa, K Higuchi, K Kogishi, H Naiki, K Hanada, F Sakiyama, T Takeda.   

Abstract

Murine apolipoprotein (apo) A-II is a serum precursor of murine senile amyloid protein. We determined the primary structures of apo A-II in accelerated senescence-prone mice (SAM-P) characterized by a high frequency of age-associated systemic amyloidosis and accelerated senescence-resistance mice (SAM-R) in which senile amyloidosis occurred with a low incidence. Apo-A-II variant (Pro5----Gln) was found to be present only in the serum of SAM-P and not in that of SAM-R or other random bred slc:ICR mice. The apo A-II variant in the serum of SAM-P is identical to the murine senile amyloid fibril protein (ASSAM) derived from amyloid-deposited tissues of SAM-P. These findings proved that apo A-II deposits in tissues without degradation and this mutation (Pro5----Gln) probably have significant effects on the structure and function of apo A-II and would play a critical role in murine senile amyloidogenesis.

Entities:  

Mesh:

Year:  1987        PMID: 3298851

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis.

Authors:  K Higuchi; K Kitagawa; H Naiki; K Hanada; M Hosokawa; T Takeda
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

2.  C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice.

Authors:  Jinko Sawashita; Beiru Zhang; Kazuhiro Hasegawa; Masayuki Mori; Hironobu Naiki; Fuyuki Kametani; Keiichi Higuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 3.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Araki; S Yi; T Murakami; S Watanabe; S Ikegawa; K Takahashi; K Yamarnura
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

4.  Metabolism of senile amyloid precursor and amyloidogenesis. Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse.

Authors:  H Naiki; K Higuchi; T Yonezu; M Hosokawa; T Takeda
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

5.  Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach.

Authors:  D A Purcell-Huynh; A Weinreb; L W Castellani; M Mehrabian; M H Doolittle; A J Lusis
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

6.  Monoamine oxidase-B-positive granular structures in the hippocampus of aged senescence-accelerated mouse (SAMP8).

Authors:  S Nakamura; I Akiguchi; N Seriu; K Ohnishi; M Takemura; M Ueno; H Tomimoto; T Kawamata; J Kimura; M Hosokawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse.

Authors:  M Takemura; S Nakamura; I Akiguchi; M Ueno; N Oka; S Ishikawa; A Shimada; J Kimura; T Takeda
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.

Authors:  S Yi; K Takahashi; M Naito; F Tashiro; S Wakasugi; S Maeda; K Shimada; K Yamamura; S Araki
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.